BioCentury
ARTICLE | Company News

Cypress Bioscience, Royalty Pharma, Ramius LLC deal

January 3, 2011 8:00 AM UTC

Ramius and Royalty extended to midnight on Jan. 5, 2011, from Dec. 30, 2010, the deadline for their tender offer to acquire the 90.1% of Cypress that Ramius does not already own for $6.50 per share. A...